Is this the best UK renewable energy ETF?

The iShares Global Clean Energy UCITS is the most popular renewable energy ETF in the UK. But is it the best? Edward Sheldon takes a look.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The most popular renewable energy exchange-traded fund (ETF) in the UK is the iShares Global Clean Energy UCITS ETF (LSE: INRG). This fund – which investors have piled into in recent years – currently has net assets of around $6.3bn.

But is INRG actually the best UK clean energy ETF to invest in? I’m not so sure. If I was looking to invest in renewable energy stocks through an ETF today, I think there could be better options for my portfolio.

The best UK renewable energy ETF?

One that looks superior to me is Lyxor New Energy UCITS ETF (LSE: NRJL). This is a smaller, more under-the-radar product with net assets of around €1.4bn.

This ETF is different to iShares Global Clean Energy in that it tracks the World Alternative Energy index. This is an index composed of the world’s 40 largest companies operating in the renewable energy, distributed energy, or energy efficiency sectors, that derive at least 40% of their revenues from alternative energy activities.

By contrast, the iShares Global Clean Energy tracks the S&P Global Clean Energy index, which is an index of around 100 clean energy-related companies in developed and emerging markets.

Better long-term performance

While the fact that these two track different indexes may not seem like a big deal, it has actually made a massive difference to performance, both in the short term and in the long term.

For example, if we look at performance this year, INRG has delivered a share price return of -13%. Meanwhile, NRJL has delivered a return of 5% (to 31 October).

Meanwhile, if we look at the 10-year returns to 31 October, INRG returned around 215% while the Lyxor fund (I’m looking at the EUR version here because it has a longer track record) returned around 295%. That’s a significant difference. 

Now these performance figures don’t tell the full story. That’s because INRG had a period of strong outperformance last year. This is illustrated by the fact that for the three years to 31 October, INRG returned around 220% while the Lyxor ETF returned around 140%.

However, I like the consistency of NRJL’s returns. I’d rather not invest in an ETF that is prone to huge price swings.

Lyxor New Energy risks

Of course, the Lyxor New Energy UCITS ETF isn’t perfect. Because it tracks an index that only has 40 renewable energy stocks, as opposed to around 100 for INRG, stock-specific risk is higher. If a handful of companies in the World Alternative Energy index blow up, this ETF could underperform. It’s worth noting that the top holding at 31 October, Schneider Electric had a 15% weighting in the index. That adds risk.

Another issue to be aware of is that the GBP version of this ETF isn’t available on all platforms. It is available on AJ Bell Youinvest while Hargreaves Lansdown only appears to have the EUR version.

Overall though, I see it as a good ETF for clean energy stocks. If I was looking to invest in renewable energy stocks via an ETF (I’m not, because I prefer to invest in individual stocks), I’d certainly consider NRJL.

Edward Sheldon has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »